P771 |
In
healthy women increasing TSH concentrations within the normal range
are associated with increasing cardiovascular risk |
|
DF Waterhouse, AM McLaughlin, F Sheehan & D
O'Shea |
P772 |
A
case of delayed diagnosis of pituitary resistance to thyroid hormone
(PRTH) |
|
A Nyunt & SM Orme |
P773 |
Relationship
between sodium iodine symporter and thyroid peroxidase expression
and cytokines production by thyrocytes from patients with immune
and non-immune thyroid disorders |
|
A Bossowski, B Czarnocka, A Stasiak-Barmuta,
K Bardadin, M Urban, A Lyczkowska, J Czerwinska & J Dadan |
P774 |
The
reference ranges of maternal thyroid hormones (thyrotropin and
free thyroxine) at the second and third trimesters of pregnancy:
impact of FT4 assays |
|
M d'Herbomez, G Forzy, R Sapin, D Houze de
l'Aulnoit, S Lepers & P Caron |
P775 |
The
effect of high calcium on activity of thyroid gland in rat |
|
F Ebrahimian & S Zahedi-Asl |
P776 |
Safety
and efficacy of administering 0.2mg of recombinant human TSH for
two consecutive days as an adjuvant to low-dose radioiodine therapy
in out-patients with large non-toxic multinodular goitre |
|
M Giusti, C Cappi, B Santaniello, E Ceresola,
C Augeri, C Lagasio & F Minuto |
P777 |
Clinical
aspects and diagnostics of follicular thyroid tumours |
|
I Abesadze, I Martirosyan, EA Troshina & NV
Mazurina |
P778 |
Prevalence
of thyroid dysfunction in old residents in the province of Pavia,
northern Italy |
|
F Magri, CA Galimberti, S Chytiris, L Chiovato & E
Ferrari |
P779 |
Thyroid
function in patients with atrial fibrillation |
|
TV Bystrova, EA Troshina, FM Abdulchabirova & LA
Panchenkova |
P780 |
Hyperthyreosis
treated with thyroid artery embolization |
|
GW Kaminski, A Jaroszuk, K Brzozowski, A
Kowalczyk, P Zukowski, Z Podgajny, P Twarkowski & M Siekierzynski |
P781 |
Psychological
wellbeing correlates with free T4 but not free T3 levels in patients
on 'adequate' thyroid hormone replacement |
|
P Saravanan, T Visser & CM Dayan |
P782 |
Correlation
between endogenous thyroxine and A, G and M immunoglobulins in
dysthyreosis |
|
A Laszlo, I Pascanu, C Gliga, A Schiopu & M
Laszlo |
P783 |
Long-term
results of decompression surgery in thyroid-associated ophthalmopathy |
|
M Jernfors, M Välimäki, A Pitkäranta,
K Setälä & K Laitinen |
P784 |
Fixed
dose radioactive iodine therapy for hyperthyroidism: the west of
Ireland experience |
|
JH McDermott & J O'Donnell |
P785 |
Pathogenic
mutations in gene RET in patients with medullary thyroid carcinoma
found in Polish population |
|
Z Paszko, M Sromek, M Czetwertynska, D Czapczak,
A Wisniewska, E Skasko, I Kozlowicz- Gudzinska, A Prokurat & M
Chrupek |
P786 |
Epidemiology
of endemic goiter in mountain region of Adjara Autonomy Republic
(Georgia) |
|
N Sekhniashvili, R Kvanchakhadze, D Tsereteli,
Z Sekhniashvili & L Baramidze |
P787 |
Epidemiologic
analysis of thyroid fine needle aspiration biopsies over a period
of 18 years (1987-2004) |
|
S Polyzos, M Kita, DG Goulis, A Benos, N
Flaris, M Leontsini & A Avramides |
P788 |
Differentiated
thyroid carcinoma - experiences from a centre in South India |
|
K Sudeep, N Thomas, M Seshadri, S Anjali,
R Oommen & TV Paul |
P789 |
Ultrasound
thyroid changes: Moscow population screening results |
|
EA Troshina, NV Mazurina, NV Galkina & IT
Martirosyan |
P790 |
Quality
of life, health status, symptoms and treatment satisfaction in
subclinical hypothyroidism: a double-blind 12-week cross-over study
of L-thyroxine versus placebo |
|
S Razvi, CV McMillan & JU Weaver |
P791 |
Loss
of heterozygosity and genetic association analyses within 11q13.5-q14
chromosomal region in papillary thyroid carcinoma |
|
R Ramirez-Lorca, E Ferrero Herrero, ME Saez,
M Labalde Martinez, LM Real, A Ruiz & M Hidalgo Pascual |
P792 |
Environmental
and socio-economic risk factors of thyroid cancer in Olsztyn and
the Warmia and Mazury region, Poland |
|
E Bandurska-Stankiewicz & E Aksamit-Bialoszewska |
P793 |
Reverse
transcriptase (RT) inhibitors down regulate tumor growth, induce
cell differentiation and re-establish iodine uptake in human thyroid
anaplastic carcinoma in vitro and in vivo |
|
M Landriscina, A Fabiano, S Altamura, C Bagalà,
A Piscazzi, N Maiorano, F Giorgino, C Barone & M Cignarelli |
P794 |
The
effect of block and replacement regime following radioiodine therapy
for thyrotoxicosis on thyroid function in the postradioiodine period |
|
B Vaidya & S Estcourt |
P795 |
Prevalence
of amiodarone-induced thyroid disorders in iodine deficiency region |
|
SI Ismailov, NL Kayumova & N Abdusalamova |
P796 |
Correction
of oxidative metabolism in myocardium by oligocrine during experimental
thyrotoxicosis |
|
M Kvirikashvili, T Sanikidze & D Metreveli |
P797 |
The
metabolic syndrome and the thyroid in euthyroidism |
|
A Roos, SJL Bakker, TP Links & BHR Wolffenbuttel |
P798 |
Thyroid
disease prevalence and incidence in a Dutch population survey |
|
A Roos, TP Links, SJL Bakker & LTW de
Jong-van den Berg |
P799 |
Increased
lipid peroxidation in critically ill patients with low-T3 syndrome |
|
M Karbownik, A Kokoszko, M Jozefiak & A
Lewinski |
P800 |
Asymmetric
dimethyl arginine levels in thyroid dysfunctions |
|
E Arikan, CH Karadag & S Guldiken |
P801 |
Results
of fine-needle aspiration biopsy of thyroid nodules in region of
mild iodine deficiency |
|
D Metreveli & K Mikadze |
P802 |
Thyroid
cancer: diagnostic role of ultrasound and ultrasound-guided fine
needle aspiration biopsy (US-FNAB) evaluation |
|
V Triggiani, E Guastamacchia, F Resta, C
Sabba & E Tafaro |
P803 |
Parathyroid
hormone determination in fine needle aspirates (PTH-FNAB) allows
the differentiation between thyroid and parathyroid lesions |
|
V Triggiani, E Guastamacchia, F Resta, C
Sabba & E Tafaro |
P804 |
Heart
rate variability in thyroidectomized patients using suppressive
therapy with thyroxine |
|
AV Kovalchuk, ST Zubkova & VN Kovalchuk |
P805 |
Clinical
value of the assessment of neopterin in Graves' ophthalmopathy |
|
A Baldys-Waligorska, B Kusnierz-Cabala, E
Placzkiewicz-Jankowska & B Huszno |
P806 |
Maternal
iodine deficiency alters learning ability and emotional state of
the progeny |
|
A Sarishvili, N Lazrishvili & D Metreveli |
P807 |
Quantitative
and qualitative evaluation of the impact of a ten-year iodine intervention
programme in rural areas of Tehran |
|
N Salarkia, F Rabiee & F Azizi |
P808 |
Effect
of oral administration of propylthiouracil during pregnancy and
lactation period on isolated aorta response of their adult male
offspring |
|
S Zahedi, M Khaksari, M Shafiee & A Gasemi |
P809 |
Study
of the prevalence and mechanisms of action of TSH receptor and
Gs protein alfasubunit mutations in toxic multinodular goiter and
toxic adenoma in Galicia (Spain) |
|
F Palos, O Perez, V Alvarez-Iglesias, J Cameselle,
F Barreiro, D Araujo, R Argueso, M Botana, JM Cabezas, L Dominguez,
T Martinez, J Nuño, JC Rueda & J Lado-Abeal |
P810 |
The
relationship between echocardiographic left atrial size and atrial
fibrillation in patients with Graves' disease |
|
IA Vaychulis & II Shaposhnik |
P811 |
ClC-5
does not affect megalin expression and function in the thyroid
gland |
|
S Lisi, T Maritzen, R Botta, A Pinchera,
C Marcocci, TJ Jentsch & M Marinò |
P812 |
RAP
(LDL receptor-associated protein) expression in thyroid epithelial
cells: evidence for TSH-dependence in vivo and in vitro |
|
R Botta, S Lisi, A Pinchera, C Segnani, L
Cianferotti, MA Altea, F Menconi, L Mattii, GU Corsini, C Marcocci,
A Dolfi, N Bernardini & M Marinò |
P813 |
Liver
enzyme alterations during high dose intravenous glucocorticoid
pulse therapy for Graves' ophthalmopathy: frequency and putative
risk factors |
|
MA Altea, E Morabito, F Menconi, R Piccione,
F Latrofa, B Mazzi, L Bartalena, A Pinchera, C Marcocci & M
Marinò |
P814 |
High-intensity
focused ultrasound (HIFU) treatment for thyroid nodules: first
clinical study |
|
OE Esnault, BF Franc, FM Ménégaux,
AR Rouxel, EDK Kerviller, PB Bourrier & LL Leenhardt |
P815 |
Digital
infra-red orbital thermography in the assessment of thyroid eye
disease |
|
SE Williams, AR Hill & BW Fleck |
P816 |
Prognostic
factors for persistent or recurrent disease from a series of 81
patients with oncocytic thyroid carcinoma |
|
CD Cao, H Mirghani, JL Wemeau, E Leteurtre,
M D'Herbomez, X Marchandise & C Proye |
P817 |
Association
of CTLA-4 exon 1 polymorphism with Graves' disease in Spanish patients |
|
P Álvarez-Vázquez, D Valverde,
L Constela, L Pérez Méndez & RV García-Mayor |
P818 |
Reference
intervals of maternal free thyroxine (FT4) at the second and third
trimesters of pregnancy using the Beckman Coulter's Access Free
T4 assay |
|
V Jarrige, H Meurisse & M D'Herbomez |
P819 |
Bioavailability
of iodine bound in humic substances in drinking water and the impact
on thyroid function |
|
S Andersen, P Gustenhoff, F Iversen, S Terpling,
KM Pedersen & P Laurberg |
P820 |
Application
of positron emission tomography (PET) in the study of cerebral
glucose uptake in hypothyroid rats: effect of T3 administration |
|
M De Servi, N Belcari, J Bernal, S Refetoff,
P Salvadori, E Gianetti, G De Marco, M Tonacchera, P Vitti, A Del
Guerra & A Pinchera |
P821 |
The
development of a symptom-based clinical activity score for thyroid
eye disease |
|
CE Elder, BW Fleck & S Rajack |
P822 |
A
qualitative study of patients' experience of thyroid eye disease |
|
CE Elder & BW Fleck |
P823 |
Etiology
of congenital hypothyroidism in children with a normal located
thyroid gland |
|
C Di Cosmo, M Tonacchera, G De Marco, P Agretti,
ME Banco, A Perri, H Ramos, C Ceccarelli, P Vitti & A Pinchera |
P824 |
Clinical
characterisation and genetic analysis of a large euthyroid family
with TSH-receptor germline mutation (N372T) and a hyperthyroid
index patient with an additional somatic TSH-receptor mutation
(S281N) on the second TSH-receptor allele |
|
HI Gozu, R Bircan, K Krohn, S Müller,
D Yavuzer, G Ekinci, H Sargin, M Sargin, E Orbay, B Cirakoglu & R
Paschke |
P825 |
Estimation
of the optimal diagnostic complex of the treatment of the nodular
euthyroid formations of thyroid |
|
V Chachibaia, B Gvadzabia, E Giorgadze & K
Mirianashvili |
P826 |
The
diagnostic value of Doppler ultrasonography in determining the
malignancy potential of thyroid nodules |
|
F Sahin, M Varer, A Sarsilmaz, G Oruk, M
Apaydin & E Uluc |
P827 |
Favourable
outcome of Graves' ophthalmopathy (GO) after glucocorticoids (GC)
in patients treated with total thyroid ablation (TTA): results
of a randomized clinical trial |
|
FM Menconi, MM Marinò, LB Bartalena,
RR Rocchi, MN Nardi, AP Pinchera & CM Marcocci |
P828 |
Lipids
profile and carotid scan atherosclerotic parameters in newly diagnosed
hypothyroid females |
|
VP Popovic-Radinovic, ZG Gluvic, MV Vujovic,
JT Tica, ZR Rasic-Milutinovic, DM Milicevic, EI Isenovic & MP
Pavicevic |
P829 |
Safety
of pharmacological treatment of thyroid diseases during pregnancy |
|
E Gianetti, M Tonacchera, L Russo, A Perri,
P Vitti & A Pinchera |
P830 |
Increase
of L-thyroxine requirement during pregnancy |
|
L Russo, M Tonacchera, E Gianetti, A Perri,
P Vitti & A Pinchera |
P831 |
Congenital
thyroid hemiagenesis in associaton with multinodular goitre - a
case report |
|
M Varer, A Sarsilmaz, G Oruk, H Akin, M Apaydin & E
Uluc |
P832 |
Insulin-like
growth factor-I counteracts 131Iinduced thyroid stunning by stimulating
the transcription of the sodium/iodide symporter (NIS) |
|
M Nordén, C Johanson, S Tedelind,
F Larsson, T Carlsson & M Nilsson |
P833 |
A
case of Riedel's thyroiditis successfully treated with glucocorticoids |
|
G Viccica, T Rago, P Berti, A Pinchera & C
Marcocci |
P834 |
An
audit of radioiodine treatment for thyrotoxicosis in Cambridge |
|
H Andreou, S Kalavalapalli, M Gurnell, H
Simpson, DF Wood, KK Balan & VKK Chatterjee |
P835 |
On-levothyroxine
measurement of thyroglobulin is not a reliable screening test for
patients at high risk of remnant/recurrent differentiated thyroid
carcinoma |
|
A Gholamrezanezhad, M Saghari, S Mirpour & D
Beiki |
P836 |
Prevalence
of somatic TSHR and Gs alpha mutations in toxic thyroid nodules
(TTNs) in endemic and non-endemic goiter areas of Turkey |
|
HI Gozu, R Bircan, K Krohn, S Müller,
S Vural, C Gezen, H Sargin, M Sargin, B Çirakoglu & R
Paschke |
P837 |
The
role of autoimmunity and thyroid function on pregnancy outcomes
in euthyroid women with autoimmune disease undergoing assisted
reproduction |
|
R Negro, G Formoso, L Coppola, G Presicce,
T Mangieri, A Pezzarossa & D Dazzi |
P838 |
Value
of routine measurement of serum calcitonin concentrations in patients
with nodular goiter: a multicenter study |
|
G Papi, SM Corsello, K Cioni, AM Pizzini,
S Corrado, C Carapezzi, G Fadda, A Baldini, C Carani, A Pontecorvi & E
Roti |
P839 |
Association
between patient- and tumorrelated factors and the gene expression
profile of papillary thyroid cancer |
|
S Szpak-Ulczok, M Wiench, M Oczko-Wojciechowska,
J Wloch, K Fujarewicz, A Swierniak, D Lange & B Jarzab |
P840 |
Levothyroxine
suppressive therapy in thyroid nodules |
|
S Azzoug, K Maachi & F Chentli |
P841 |
Levothyroxine
suppressive therapy and body composition |
|
S Dubois-Ginouves, S Laboureau-Soares Barbosa,
JF Dumas, P Abraham, A Sallé, F Illouz, P Rodien, P Ritz & V
Rohmer |
P842 |
Differential
regulation of soluble Fas in patients with autoimmune thyroid disease |
|
S Fountoulakis, N Kolaitis, G Philippou,
G Vartholomatos & A Tsatsoulis |
P843 |
Application
of new technology of anti-DNA antibodies detection in diagnostics
of autoimmune thyroiditis |
|
G Vagapova, L Anchikova, O Konovalova, L
Sattarova, E Podshivalina, V Vinter & M Salahov |
P844 |
Thyroxine
replacement dose in patients with Hashimoto disease: a potential
role for interleukin-6 |
|
NP Papanas, DP Papazoglou, KP Papatheodorou,
LP Papazoglou, TE Exiara, MB Bitsakaki, SK Kotsiou & EM Maltezos |
P845 |
The
glutathione peroxidase 3 promoter is activated by Pax8 |
|
B Mentrup, N Renault, C Schmutzler & J
Köhrle |
P846 |
Similarities
in the role of FoxE1 in thyrocytes and keratinocytes? |
|
M Bullock, M Jehani, P Bowden & M Ludgate |
P847 |
Inhibin
B/inhibin binding protein complex is differentially expressed in
normal and nodular human thyroid tissue |
|
M Della Guardia, A Franchi, S Nardo, MG Santaguida,
R Sibilla & M Centanni |
P848 |
Towards
the development of a valid quality of life questionnaire for patients
with thyroid diseases: which questions shall we ask? |
|
T Watt, M Groenvold, AK Rasmussen, SJ Bonnema,
L Hegedüs, JB Bjorner & U Feldt-Rasmussen |
P849 |
The
efficacy of levothyroxine therapy in the nontoxic multinodular
goiter |
|
AM Mihai, AE Ranetti, C Spiroiu, A Mazilu & C
Ranetti |
P850 |
Association
of the FCRL3 gene with Graves' disease in the UK Caucasian population |
|
MJ Simmonds, JM Heward, J Carr-Smith, JA
Franklyn & SCL Gough |
P851 |
Treatment
options in progressive medullary, follicular, and papillary thyroid
carcinomas: evaluation of chemotherapy with doxorubicin |
|
A Matuszczyk, A Bockisch, P Veit, K Mann & S
Petersenn |
P852 |
Staging
of progressive papillary, follicular, or medullary thyroid carcinomas:
comparison of various staging procedures to define the extent and
progress of disease |
|
A Matuszczyk, S Petersenn, A Bockisch, S
Sheu, P Veit & K Mann |
P853 |
The
effect of obesity and weight loss on thyroid hormone status |
|
L Keskin, I Sahin, R Bentli, S Senel & C
Taskapan |
P854 |
The
research of IQ level in school children who live in the regions
with iodine deficiency |
|
SL Slovjeva, A Troshina & AO Zhukov |
P855 |
Unmasking
of central hypothyroidism following growth hormone replacement
in adult hypopituitary patients |
|
A Agha, D Walker, WM Drake, SL Chew, AB Grossman,
PJ Jenkins & JP Monson |
P856 |
Somatostatin
receptor scintigraphy with 99mTc-HYNIC-TATE in visualization of
nonradioiodine- avid differentiated thyroid carcinoma |
|
Z Podgajny, G Kaminski, N Szalus, A Kowalczyk,
J Pietrzykowski, A Jaroszuk & M Siekierzynski |
P857 |
A
novel test with recombinant human TSH for the differential diagnosis
of congenital hypothyroidism in pediatric age |
|
L Fugazzola, G Weber, D Mannavola, G Vannucchi,
M Carletto, V Longari, L Persani & P Beck-Peccoz |
P858 |
The
use of recombinant human thyrotropin (rhTSH) in amiodarone-induced
hyperthyroidism |
|
Z Adamczewski, J Makarewicz, M Knapska- Kucharska,
L Oszukowska, A Karwowska & A Lewinski |
P859 |
Thyrotropin
receptor (TSHR) activation has variable effects on the TNF alpha
axis in preadipocytes and osteoblast-like cell lines |
|
M Mandrikoula, M Henry, BAJ Evans & M
Ludgate |
P860 |
Follicular
and Hürthle thyroid nodule at cytology: diagnostic value of
nuclear atypia cell neoplasia |
|
T Rago, G Di Coscio, F Basolo, M Scutari,
P Berti, R Romani, P Faviana, P Miccoli, A Pinchera & P Vitti |
P861 |
The
use of Konjac glucomannan to lower serum thyroid hormones in hyperthyroidism |
|
T Bayraktaroglu, F Kutluturk, A Azezli, Y
Orhan & S Tanyolac |
P862 |
Comparison
of the effects of thyrotropin receptor (TSHR) activation on preadipocyte
cell lines from white (WAT) and brown (BAT) adipose tissue |
|
L Zhang, C Paddon, GC Baker & M Ludgate |
P863 |
Effects
of increment of endogenous TSH levels on the effective half-life
time of 131I and iodine uptake by thyroid remnants in patients
after thyroidectomy |
|
M Knapska-Kucharska, J Makarewicz, L Oszukowska,
Z Adamczewski & A Lewinski |
P864 |
Surgery
should be considered equally with 131I and thionamide treatment
as first line therapy for thyrotoxicosis |
|
T Sathyapalan, SL Atkin & RJA England |
P865 |
Thyrotoxicosis
- a risk factor for subsequent development of osteoporosis? |
|
T Zimmermann-Belsing, B Langdahl, P Charles & U
Feldt-Rasmussen |
P866 |
Relationship
between cardiac arrhythmias and subclinical hyperthyroidism |
|
P De Remigis, L Vianale, A De Remigis, P
Sabatini & E Di Girolamo |
P867 |
Cardiovascular
disease in patients with and without hypothyroidism |
|
C Neves, JL Medina & F Lopes |
P868 |
Clinical
parameters and echographic patterns are poor predictors of malignancy
in follicular and Hürthle cell nodules at cytology |
|
T Rago, G Di Coscio, F Basolo, M Scutari,
P Berti, R Romani, P Faviana, P Miccoli, A Pinchera & P Vitti |
P869 |
Identification
of housekeeping genes useful for the normalization of RNA in studies
of gene expression in thyroid carcinomas |
|
P Piampiani, C Romei, B Cosci, A Vivaldi,
R Ciampi, A Pinchera & R Elisei |
P870 |
Identification
of a novel germ-line point mutation of the RET gene (Met848Thr)
in a patient affected by medullary thyroid carcinoma and Castleman's
syndrome |
|
B Cosci, M Altea, M Castagna, C Romei, P
Piampiani, A Vivaldi, R Ciampi, P Faviana, F Basolo, A Pinchera & R
Elisei |
P871 |
Usefulness
of molecular analysis of BRAF mutation and RET/PTC rearrangements
in fine needle aspiration (FNA) of thyroid nodules with non-diagnostic
cytology |
|
C Romei, T Rago, M Scutari, V Bottici, G
Di Coscio, F Basolo, P Berti, A Pinchera, P Vitti & R Elisei |
P872 |
Does
selenium deficit trigger post partum thyroiditis? |
|
HG Bohnet |
P873 |
17-AAG
and DIDS increase the iodide retention time in thyroid cancer cells
transfected with NIS |
|
A Vivaldi, R Ciampi, F Santini, B Cosci,
P Piampiani, C Romei, A Pinchera & R Elisei |
P874 |
Demethylating
treatment with azacytidine induces retinoic acid receptor RAR beta
expression in human thyroid cancer cells |
|
FY Miasaki, A Vivaldi, R Ciampi, L Agate,
B Cosci, P Piampiani, C Romei, A Pinchera & R Elisei |
P875 |
Free
thyroxine (FT4) is the analyte of choice in early gestation |
|
B Dando, R Taylor, R Henley, AB Parkes, R
John & JH Lazarus |
P876 |
Comparison
of TPOAb assays in early pregnancy |
|
R Henley, AB Parkes, L Taylor, R John & JH
Lazarus |
P877 |
Age
and gender differences and phenotypes of patients with autoimmune
thyroid disease - the UK AITD consortium |
|
JD Carr-Smith, N Manji, K Boelaert, A Allahabadia,
M Armitage, J Lazarus, S Pearce, B Viadja, SC Gough & JA Franklyn |
P878 |
Influence
of family history on the age of presentation of AITD - the UK AITD
consortium |
|
N Manji, JD Carr-Smith, K Boelaert, A Allahabadia,
M Armitage, J Lazarus, S Pearce, B Viadja, SC Gough & JA Franklyn |
P879 |
Prevalence
of thyroid dysfunction and other autoimmune disorders within the
families of subjects with autoimmune thyroid disease - the UK AITD
consortium |
|
N Manji, JD Carr-Smith, MJ Simmonds, A Allahabadia,
M Armitage, J Lazarus, S Pearce, B Viadja, JA Franklyn & SC
Gough |
P880 |
Do
SNPs within the PTPN22 gene contribute to autoimmune disease via
different mechanisms? |
|
J Heward, M Simmonds, JA Franklyn & SC
Gough |
P881 |
Screening
of autoimmune thyroid disorders in pregnancy in a highland district |
|
J Horacek, S Spitalnikova, J Cepkova, V Ceeova,
J Dolezal, J Vizda & J Maly |
P882 |
Gene
expression profile in functioning and non-functioning nodules of
autonomous multinodular goiters from an area of iodine deficiency |
|
P Agretti, G de Marco, M de Servi, E Gianetti,
F Basolo, A Pinchera, P Vitti & M Tonacchera |
P883 |
Comparison
of efficiency of iodine-prophylaxis in healthy pregnant women and
pregnant women with non-toxic goiter, living in a region with mild
iodine-deficiency |
|
TPS Shestakova, AVD Dreval & OAN Nechaeva |
P884 |
Gene
expression profile in orbital fibroblasts from a TAO patient before
and after adipocytic differentiation |
|
P Agretti, G de Marco, E Ferrarini, A Dimida,
D Sansone, M Banco, M de Servi, S Lisi, C Marcocci, M Marinò,
P Vitti, A Pinchera & M Tonacchera |
P885 |
Is
subclinical hyperthyroidism associated with blood pressure and
hypertension? |
|
H Völzke, M Dörr & H Wallaschofski |
P886 |
Thyrotoxicosis
in childhood. UK and Ireland Surveillance Study 2004-2005 |
|
SM Williamson & SA Greene |
P887 |
PKA
II mediates cAMP-dependent phosphorylation of CREB and activation
of gene transcription in differentiated rat thyroid cells |
|
D Calebiro, T de Filippis, S Lucchi, P Porrazzi,
P Beck-Peccoz & L Persani |
P888 |
Transcriptomic
analysis of the oncocytic signal in vesicular thyroid tumours |
|
JF Fontaine, F Savagner, M Melo, B Ballester,
R Houlgatte & Y Malthièry |
P889 |
Application
of MRI in the differential diagnosis of different forms of Hashimoto's
thyroiditis in patients from the iodine deficient region |
|
G Vagapova & I Mikhailov |
P890 |
Immunohistochemical
staining for thyroid peroxidase (TPO) of TRU-CUT biopsies from
scintigraphically cold thyroid nodules |
|
U Yousaf, L Christensen, AK Rasmussen, F
Jensen, E Hilmer, C Mollerup, J Kirkegaard, I Lausen & U Feldt-Rasmussen |
P891 |
Regulation
of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone
(T3): identification of a thyroid hormone response element (TRE)
in the murine Fgfr1 promoter |
|
PJ O'Shea, GR Williams & SY Cheng |
P892 |
Subclinical
hypothyroidism - how soon to treat? |
|
S Ghita, M Musat, M Simescu, E Balmes, H
Ursu, C Badiu & G Totoianu |
P893 |
Cytostatic
effect of plitidepsin (aplidintm) in human undifferentiated (anaplastic)
thyroid carcinoma |
|
S Bravo, M Garcia-Renduelles, R Seoane, V
Dosil, J Cameselle, L Lopez-Lázaro, J Zalvide, F Barreiro,
C Pombo & C Alvarez |
P894 |
A
case of severe thyrotoxic hypercalcaemia |
|
VKB Prabhakar & PJ Hale |
P895 |
Efficacy
of high dose radioiodine in the treatment of elevated serum thyroglobulin
in patients with differentiated thyroid carcinoma and negative
whole body iodine scan |
|
A Gholamrezanezhad, M Saghari, S Mirpour,
D Beiki & B Fallahi |
P896 |
Isometric
tension studies in a transgenic mouse model of thyroid hormone
resistance |
|
PJD Owen, D Tomlinson, H Ying, D Lang, SY
Cheng & JH Lazarus |
P897 |
The
GH response to ghrelin in humans is reduced in conditions of hyper-
and hypothyroidism |
|
F Broglio, F Prodam, F Riganti, E Gramaglia,
R Rossetto, M Maccario & E Ghigo |
P898 |
Multicenter
evaluation of the Abbott Architect anti-Tg and anti-TPO assays |
|
R Anarat, C Bena, H Garth, M Klein, A Radicioni,
S Schmitt, C Smith, S Szepanski, M Turanchik & J Waterston |
P899 |
Autoantibody
profile in patients with Graves' disease and thyroid-associated
ophthalmopathy |
|
NV Latkina, IA Ilovayskaya & IV Kryukova |
P900 |
Treatment
of disseminated non-radioiodine- AVID papillary thyroid cancer
with 90Y-DOTATATE preparation |
|
N Szalus, G Kaminski, K Obuchowski, J Pietrzykowski,
Z Podgajny, M Zagrodzka & E Dziuk |
P901 |
Hashimoto's
thyroiditis in the children. Clinical features at presentation |
|
VT Skarpa, ED Kostakioti, AK Tertipi, PA
Petrou, E Posnaghidou, M Anastasakou, P Papahilleos, A Papathanasiou & C
Hadjiathanasiou |
P902 |
Corticotherapy
alone or corticotherapy combined with orbital radiotherapy in severe
active Graves' ophthalmopathy: therapeutic outcome in 905 patients |
|
H Jastrzebska, M Gietka-Czernel, J Janik,
S Zgliczynski, R Karczmarzyk & J Fijuth |
P903 |
The
effects of treatment with L-thyroxine on level of prolactin, CRP
and insulin in premenopausal women with subclinical hypothyroidism |
|
Z Velija-Asimi & B Heljic |
P904 |
Modifications
in the frequency of presentation and the TNM stage at diagnosis
of thyroid carcinoma in the last decade in Valencia (Spain) |
|
J Yanini, R Casañ, K García,
A Jover, M Gómez, E Solá, C Morillas, H Peña,
ML Muñoz & A Hernández |
P905 |
Pretreatment
with rhTSH allows effective 131I therapy in patients with multinodular
toxic goiter and low radioiodine uptake |
|
M Gietka-Czernel, H Jastrzebska, W Zgliczynski,
G Wasniewska, M Wróblewska, K Wernic, B Cybulska & E
Karpin´ska |
P906 |
Repression
of the human NIS upstream enhancer (hNUE) by PTTG |
|
VE Smith, K Boelaert, AL Stratford, SR James,
R Susarla, T Kogai, MC Eggo, JA Franklyn & CJ McCabe |
P907 |
Comparison
of cytogenetic damage in patients with differentiated thyroid cancer
receiving ablative 131I therapy in the hypothyroid status versus
the euthyroid status (rhTSH assisted treatment) |
|
A Frigo, G Francia, MV Davi, G Boni, C Traino,
L Scilanga, F Bernardi, G Mariani, A Vaiano, C Colato, V lo Cascio & M
Ferdeghini |
P908 |
Correction
of hypomagnesaemia improves the symptoms of hypocalcaemia after
thyroidectomy |
|
MFA Abdelhamid, MS Barsoum, SA Shaheen & LA
Mansour |
P909 |
The
thyroid gland and its selenoenzymes are preferentially supplied
in selenium-deficient transgenic mice |
|
L Schomburg, C Riese, M Michaelis, E Griebert,
MO Klein, R Sapin, U Schweizer & J Koehrle |
P910 |
Changes
in thyroxine requirement in the longterm follow-up of hypothyroid
patients |
|
AK Viswanath, A Avenell, S Philip, S Acharya,
G MacLennan, K Dalziel, SA Copland, JS Bevan & P Abraham |
P911 |
Problems
of identifying independent non-class II susceptibility loci within
the HLA region for Graves' disease |
|
MJ Simmonds, JM Heward, JA Franklyn & SCL
Gough |
P912 |
Is
131I therapy for hyperthyroidism harmful for testis function? |
|
C Ceccarelli, D Canale, E Fiore, C Moschini,
C Caglieresi, P Vitti & A Pinchera |
P913 |
What
is the most effective screening interval in the long-term follow-up
of stable hypothyroid patients on thyroxine? |
|
AK Viswanath, A Avenell, S Philip, S Acharya,
G MacLennan, K Dalziel, O Pereira, SA Copland, JS Bevan & P
Abraham |
P914 |
Expression
and signal transduction of the cAMP-binding protein Epac in thyroid
cells and thyroid tumors |
|
M Broecker-Preuss, S-Y Sheu, J Baten, M Bollepalli,
M Schmidt, KW Schmid & K Mann |
P915 |
Orbital
tissue expansion expressed as a number: usefulness in grading the
severity of thyroid-associated ophthalmopathy (TAO) |
|
GM Vannucchi, I Campi, S Avignone, AM Minetti,
C Guastella, F Sbrozzi, P Beck-Peccoz & M Salvi |
P916 |
Radioiodine
treatment for hyperthyroidism - do Royal College guidelines suggest
too high a radioiodine dose? |
|
R Zakir Ahmed & J P Hosker |
P917 |
Thyroid
cancer management: are guidelines being met? |
|
HS Chahal, S Velmurugan, SA Mellish, R Lewis,
KA Metcalfe & JA Ahlquist |
P918 |
Treatment
of patients with Graves' disease and ophthalmopathy with the anti-CD20
monoclonal antibody rituximab |
|
M Salvi, GM Vannucchi, I Campi, C Guastella,
F Sbrozzi, S Simonetta, S Rossi, P Bonara, S Avignone & R Ratiglia |
P919 |
Withdrawal
of alfacalcidol supplements following thyroidectomy: baseline plasma
PTH predicts successful outcome |
|
M Morris & P Perros |
P920 |
Treatment
of pretibial myxedema with dexamethasone injected subcutaneously
by mesotherapy needles |
|
I Campi, GM Vannucchi, L Forzenigo, P Beck-Peccoz & M
Salvi |
P921 |
Radioiodine
uptake test reduces duration of restrictions following radioiodine
therapy for management of hyperthyroidism |
|
VN Cherukuri, M Edavalath, N Iqbal, SL Ryan,
BM Singh & HN Buch |
P922 |
The
distance between histotypes of differentiated thyroid cancer: gene
expression profiling study |
|
B Jarzab, J Wloch, D Lange, M Oczko- Wojciechowska,
E Chmielik, A Czarniecka, M Kowalska, K Fujarewicz, K Simek, G
Gala & A Swierniak |
P923 |
The
risk of hypercholesterolemia in patients with subclinical hypothyroidism |
|
L Marina, Z Penezic, S Vujovic, M Stojanovic,
M Ivovic & M Drezgic |
P924 |
Audit
of management of hypothyroidism in a joint endocrine/antenatal
clinic |
|
N Batra, E Ferriman & PE Belchetz |
P925 |
Thyrotoxicosis
is coupled with quantitative and qualitative sleep disruptions |
|
F Riganti, F Prodam, E Gramaglia, E van Cauter,
E Ghigo & F Broglio |
P926 |
The
Gods placed the diagnosis before the therapy: case reports of the
Slovak families with resistance to thyroid hormones |
|
P Vanuga, E Mendelova, G Fodor, K Vitesnik,
F Savagner, Y Malthiery & M Pura |
P927 |
Epidemiology
of thyroid cancer in Republic of Sakha during 1970-2001 |
|
A Makarov, E Makarova, V Argunov & F
Ivanova |
P928 |
Rate
of decrease in anti-thyroid antibody levels after therapeutic intervention
in patients with thyroid cancer |
|
D Thomas, I Kostoglou-Athanassiou, E Vassiliou,
V Liakos, N Mytakidis, F Chatzimarkou, P Athanassiou & P Kaldrymidis |
P929 |
Futher
results of treatment and outcomes in patients with subacute thyroiditis
observed in the period from 1993 to 2005 |
|
EV Petrova, NM Platonova, LA Kabelnitskaya & EA
Troshina |
P930 |
Cowden
syndrome - a clinical entity to be aware of |
|
O Schmiedel, K Becker & JK Platts |
P931 |
Fine-needle
aspiration biopsy of thyroid nodules |
|
S Radenkovic, M Pes¢ic, R Kocic, D Dimic,
D Mikic & M Velojic Golubovic |
P932 |
Palpation
versus ultrasonography-guided fineneedle aspiration biopsy of thyroid
nodules in endemic goiter area |
|
BK Koroglu, N Tamer, M Koroglu, NE Gulcelik & O
Aksu |
P933 |
Thyroid
storm induced cardiomyopathy is reversible |
|
NM Neary, AEC Fountain, ECI Hatfield, KF
Fox & K Meeran |
P934 |
Medullary
thyroid carcinoma - which test is the best? |
|
D Ciobanu, C Vulpoi, B Galusca, L Andriescu,
A Grigorovici, C Cristea, V Mogos, MS Mihailovici & E Zbranca |
P935 |
Glutamic
acid decarboxylase (GAD) and antityrosine phosphatase (IA2) antibody
positivity in newly-diagnosed Graves' disease patients |
|
A Harmanci, M Bayraktar, G Hascelik & A
Gurlek |
P936 |
Hyperthyroidism
presenting as ventricular fibrillation |
|
LR Chilukuri, Z Merza & TH Jones |
P937 |
Heart
rate dynamics in hyperthyroidism |
|
J-L Chen, Y-J Tseng & W-C Chu |
P938 |
Impact
of TNM classification categories on thyroid gland carcinoma |
|
P Sykorova, P Vlcek, L Jirsa & K Personova |
P939 |
Antiproliferative
effects of SOM230 on orbital fibroblasts from active Graves' ophthalmopathy |
|
D Pasquali, V Rossi, G Bellastella, D Esposito,
MC Quinto, A Bellastella & AA Sinisi |
P940 |
Further
results of treatment and outcomes in patients with subacute thyroiditis
observed in the period from 1993 to 2005 |
|
LA Kabelnitskaya, EB Petrova, N Platonova & EA
Troshina |
P941 |
Age
related changes of soluble Fas, Fas ligand and Bcl-2 in autoimmune
thyroid diseases |
|
JK Mysliwiec, M Oklota, A Nikolajuk & M
Gorska |
P942 |
Comparison
of radioiodine with radioiodine plus lithium in the treatment of
hyperthyroidism |
|
K Ahmed, GMK Nijher, A Banerjee, J Frank & K
Meeran |
P943 |
Monitoring
of goiter and urinary iodine excretion in 6- to10-year-old school
children in Ahvaz (2003-2004) |
|
H Shahbazian & S Saiedinia |
P944 |
Prevalence
of subclinical dysfunctions of thyroid gland in women older than
40 years |
|
S Glonti, L Jashi, G Tsetskhladze & T
Rukhadze |
